Polymorphism of the parasite lactate dehydrogenase gene from Plasmodium vivax Korean isolates

View Malaria Journal article here

Routine parallel diagnosis of malaria using microscopy and the malaria rapid diagnostic test SD 05FK60: the experience of Medecins Sans Frontieres in Myanmar

View Malaria Journal article here

Passion is absolutely critical if you want to be a good leader

Dr Fatoumata Nafo-Traoré, executive director of Roll Back Malaria talks about her career and calls for a rights-based approach to development.

View The Guardian interview here

A potential threat to malaria elimination: extensive deltamethrin and DDT resistance to Anopheles sinensis from the malaria-endemic areas in China

View Malaria Journal article here

Position Available: Elimination Program Adviser in Solomon Islands (PacMISC)

Terms of Reference for the position can be viewed here

Key Selection Criteria can be viewed here

Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates

View Malaria Journal article here

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia

View Nature Genetics article here

Malaria control deal signed

View Bangkok Post article here

Update on Asia-Pacific Leaders Malaria Alliance (APLMA)

View the press release from the Prime Minister of Australia here

View AusAID news release here

Biodiversity Can Help Prevent Malaria Outbreaks in Tropical Forests

View PLOS Neglected Tropical Diseases article here

Community-directed educational intervention for malaria elimination in Bhutan: quasi-experimental study in malaria endemic areas of Sarpang district

View Malaria Journal article here

Verification of clinically diagnosed cases during malaria elimination programme in Guizhou Province of China

View Malaria Journal article here

First case of Plasmodium knowlesi infection in a Japanese traveller returning from Malaysia

View Malaria Journal article here

Malaria burden in irregular migrants returning to Sri Lanka from human smuggling operations in West Africa and implications for a country reaching malaria elimination

View Transitions of the Royal Society of Tropical Medicine & Hygiene article here

Field evaluation of HRP2 and pan pLDH-based immunochromatographic assay in therapeutic monitoring of uncomplicated falciparum malaria in Myanmar

View Malaria Journal article here

10 international companies identified to supply Vanuatu medical supplies

View Vanuatu Daily Post article here

Imperfect Duplicate Insertions Type of Mutations in Plasmepsin V Modulates Binding Properties of PEXEL Motifs of Export Proteins in Indian Plasmodium vivax

Voew PLOS ONE article here

Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report

View Malaria Journal article here

Hypokalaemic paralysis in an adult case of Plasmodium vivax malaria

View Malaria Journal article here

Advances in Plasmodium vivax Malaria Research

May 28 - 29, 2013
Barcelona, Spain
CosmoCaixa, Barcelona

Malaria accounts for approximately 250 million clinical cases and nearly 1 million deaths annually, mostly in children, in 109 countries. There has been growing evidence that Plasmodium vivax is the most widely distributed malaria parasite, responsible for a significant burden of global disease and accounting for the majority of malaria cases in Latin America and Asia. Despite the increasing awareness that the overall burden, economic impact, and severity of P. vivax disease have been underestimated, this species remains underrepresented in the scientific literature and professional fora.

This 2-day conference will convene a global community of researchers to discuss P. vivax molecular biology and genomics, host–parasite interactions, novel research techniques (e.g., 'omics) to overcome barriers to in vitro, in vivo, and clinical study of P. vivax; drug resistance and drug discovery; and recent clinical trial and in-field efforts in P. vivax prevention, treatment, control, and elimination.

Presented by The New York Academy of Sciences, the "la Caixa" Foundation, B-DEBATE, Barcelona Institute for Global Health (ISGlobal), and the Barcelona Centre for International Health Research (CRESIB)

Please click here for more information